Some states require you to try and fail other weight loss interventions like dietary counseling, exercise programs, or older weight loss medications before approving a GLP-1
Your provider should interpret results in your complete health context
Ginger can be magic for nausea
And in August, Pfizer ended development of its third and final oral GLP-1 candidate, PF-06954522, after a review of its phase 1 clinical performance and the overall GLP-1 landscape
It varies depending on the form (pill or injection), the condition youre taking semaglutide for, and the type of semaglutide medication you're taking (Ozempic, Wegovy or Rybelsus)
Semaglutide protects the heart even in people without diabetes